Use of SGLT2 inhibitors in primary care

This module outlines SGLT2 inhibitor CVOT data, safety information and practical guidance for primary care physicians treating patients with T2D, cardiovascular and/or kidney disease.

Use of SGLT2 inhibitors in primary care
Rate this content
  • Use of SGLT2 inhibitors in primary care
  • Use of SGLT2 inhibitors in primary care
  • Use of SGLT2 inhibitors in primary care
  • CV and kidney disease are major contributors to the burden of T2D
  • Life expectancy is reduced in patients with diabetes and CV disease or CKD
Do you want to go to the Presentation Builder section to create a new presentation?
Cancel Go